Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-025860

Chief Executive Officer sold 5,675 shares at $224.64 ($1,274,837)

  • Chief Executive Officer acquired 5,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2022-11-15 Option exercise +5,675 $57.76 $327,788 419,699 D: show line 1 in the form
Farrell Michael J. Chief Executive Officer 2022-11-15 Sale −5,675 $224.64 $1,274,837 414,024 D: show line 2 in the form
Open-market sales · 5,675 sh · avg $224.64 · $1,274,837

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2022-11-15 Option exercise · ResMed Common Stock Options −5,675 71,565 D: show line 3 in the form
Loading xslF345X03/form4.xml…